GC Green Cross Wellbeing Successfully Holds Barun Checkup Network Roundtable

GC Green Cross Wellbeing announced on the 26th that it held the "Barun Checkup Network Roundtable" at the Conrad Seoul Hotel in Seoul on the 23rd, under the theme "Screening and Treatment Programs Applicable to Gut & Liver."

This roundtable was chaired by Dr. Woo Sungyong, former president of the Korea Barun Checkup Research Society, and brought together medical experts to discuss "Appropriate Treatment Programs During Checkups" and "Latest Insights on Bowel Cleansing Agents." In particular, the event featured the sharing of the latest insights on nutritional therapy programs, including Laennec Injection (hydrolyzed human placenta extract), and the newly improved bowel cleansing agent for colonoscopy, "Oneprep 1.38 Acid."

On the 23rd, GC Green Cross Wellbeing held a "Barun Checkup Network Roundtable" at the Conrad Seoul Hotel in Seoul under the theme "Screening and Treatment Programs Applicable to Gut & Liver." Photo by GC Green Cross Wellbeing

The detailed sessions included: ▲ Introduction to the Latest Insights and Major Guidelines on Bowel Cleansing Agents (Dr. Woo Seungmin, Seoul OK Internal Medicine Clinic) ▲ Review of the Efficacy and Safety of Bowel Cleansing Agents (Dr. Hwang Geumbit, Uri Best Internal Medicine Clinic) ▲ Nutritional Injection Therapy Programs Effective for Gut & Liver Diseases (Dr. Jeong Dogam, Dawell Internal Medicine Checkup Center) ▲ Appropriate Application of Probiotics in Gastrointestinal Diseases (Dr. Sung Junmin, Seoul Euddeum Internal Medicine Clinic).

Dr. Woo Sungyong (Woosungyong 1 Internal Medicine Clinic), who chaired the event, stated, "Recently, more patients are expressing a desire for care that goes beyond just treatment," adding, "It was a meaningful opportunity to discuss the latest insights into optimized treatment programs that can be applied to patients during health checkups."

Dr. Woo Seungmin (Seoul OK Internal Medicine Clinic) said, "When prescribing bowel cleansing agents for colonoscopy, it is most important to consider the patient's underlying conditions and characteristics." Dr. Hwang Geumbit (Uri Best Internal Medicine Clinic) added, "Oneprep 1.38 Acid, with its sulfate-free formulation and the lowest required dosage in Korea, can reduce the burden on patients and is expected to contribute positively to increasing colonoscopy uptake rates."

Additionally, Dr. Jeong Dogam (Dawell Internal Medicine Checkup Center) explained that "L-glutamine, which can be administered intravenously or orally, is effective in treating intestinal diseases by improving the tight junctions of intestinal epithelial cells," and that "the hepatocyte regeneration and detoxification effects of hydrolyzed human placenta extract may allow its application in the treatment of patients with chronic liver diseases."

Furthermore, Dr. Sung Junmin (Seoul Euddeum Internal Medicine Clinic) discussed "approaches to probiotics effective in treating the gut microbiome, which can be disrupted after intestinal diseases or colonoscopy," and noted that "there is a growing demand for probiotic products that minimize allergenic substances such as artificial additives."

Han Jeongyeop, Head of the IP Division at GC Green Cross Wellbeing, stated, "This roundtable was a meaningful opportunity to share the excellence of GC Green Cross Wellbeing products, which are leading the field of care beyond treatment, as well as the latest know-how in treatment programs." He added, "Going forward, we will continue to promote the effectiveness of products such as Laennec Injection, Oneprep 1.38 Acid, and Dipeptiven Injection, focusing on the Gut & Liver treatment area, and we ask for your continued interest and support."